Chemed (NYSE:CHE) Director Sells $101,080.00 in Stock

Chemed Corporation (NYSE:CHE) Director Patrick Grace sold 190 shares of the business’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. This represents a 5.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Chemed Stock Up 1.1%

Chemed stock opened at $545.55 on Thursday. The company has a market cap of $7.13 billion, a P/E ratio of 27.40, a price-to-earnings-growth ratio of 2.04 and a beta of 0.51. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $551.68. The company has a fifty day simple moving average of $473.28 and a 200 day simple moving average of $438.37. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same period in the previous year, the firm posted $4.27 EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Research analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio is presently 12.05%.

Analyst Ratings Changes

Several research firms have issued reports on CHE. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Royal Bank Of Canada boosted their target price on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Finally, Oppenheimer raised their price target on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Chemed currently has a consensus rating of “Hold” and a consensus price target of $530.75.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in CHE. Northwestern Mutual Wealth Management Co. boosted its position in shares of Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares in the last quarter. JPMorgan Chase & Co. raised its position in Chemed by 4.4% during the fourth quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock valued at $223,301,000 after purchasing an additional 21,932 shares in the last quarter. AQR Capital Management LLC raised its position in Chemed by 89.2% during the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after purchasing an additional 153,469 shares in the last quarter. TD Asset Management Inc lifted its stake in Chemed by 7.5% during the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after purchasing an additional 22,715 shares during the last quarter. Finally, Epoch Investment Partners Inc. lifted its stake in Chemed by 4.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock worth $137,945,000 after purchasing an additional 15,133 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.